FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

34743311000001106: Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Sep 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105013701000001118 Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105013801000001110 Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Has dispensed dose form Soluble tablet true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Is a Dexamethasone 2mg soluble tablets sugar free 50 tablet true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Has AMP Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Has specific active ingredient Dexamethasone sodium phosphate true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Has dispensed dose form Soluble tablet false Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dexamethasone true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Has basis of strength substance Dexamethasone true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Has dispensed dose form Soluble tablet false Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Has dispensed dose form Soluble tablet false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start